Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study)

International Journal of Obesity

Volumn 28, Issue 5, 2004, Pages 706-709

  Solati, M ^a   Ghanbarian, A ^a   Rahmani, M ^a   Sarbazi, N ^a   Allahverdian, S ^a   Azizi, F ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shahid Beheshti University of Medical Sciences   (Iran)

Author keywords

Cardiovascular risk factors; Hypertriglycemic waist; Triglyceride; Waist circumference

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; HUMAN; HYPERTRIGLYCERIDEMIA; LABORATORY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; HYPERTRIGLYCERIDEMIA; IRAN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 2342502678     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802582     Document Type: Article

References (22)

1. Sniderman AD, Dagenais GR, Cantin B, Despres JP, Lamarche B. High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol. Am J Cardiol 2001; 87 (6): 792-793.
2. Tiret L, Gerdes C, Murphy MJ, Dallongeville J, Nicaud V, O'Reilly DS, Beisiegel U, De Backer G. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study). Eur J Clin Invest 2000; 30 (7): 578-585.
3. Azizi F, Rahmani M, Raiszadeh F, Solati M, Navab M. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease. Coron Artery Dis 2002; 13 (1): 9-16.
4. Yarnell JW, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J 1994; 71 (3): 293-296.
5. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenals GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334 (15): 952-957.
6. Despres JP. Health consequences of visceral obesity. Ann Med 2001; 33 (8): 534-541.
7. Lemieux I, Couillard C, Pascot A, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Despres JP. The small, dense LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis 2000; 153 (2): 423-432.
8. Coughlan BJ, Sorrentino MJ. Does hypertriglyceridemia increase risk for CAD? Growing evidence suggests it plays a role. PosTgrad Med 2000; 108 (7): 77-84.
9. Voors AA, van Brussel BL, Kelder JC, Plokker HW. Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation. Am J Cardiol 1997; 79 (10): 1350-1354.
10. St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Despres JP, Gaudet D. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol 2002; 90 (1): 15-18.
11. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002; 10 (Suppl 2): 97S-104S.
12. Bard JM, Charles MA, Juhan-Vague I, Vague P, Andre P, Safar M, Fruchart JC, Eschwege E. BIGPRO Study Group. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol 2001; 21 (3): 407-414.
13. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres JP. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) In men? Circulation 2000; 102 (2): 179-184.
14. Azizi F, Rahmani M, Madjid M, Allahverdian S, Ghanbili J, Ghanbarian A, Hajipour R. Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study. Eur J Epidemiol 2001; 17 (3): 281-288.
15. Lemieux I, Almeras N, Mauriege P, Blanchet C, Dewailly E, Bergeron J, Depres JP. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18 (7): 725-732.
16. Haidari M, Moghadam M, Chinicar M, Ahmadieh A, Doosti M. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients. Clin Biochem 2001; 34 (2): 149-155.
17. Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002; 22 (11): 1918-1923.
18. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994; 14 (7): 1098-1104.
19. Kruszelnicka-Kwiatkowska O, Surdacki A, Goldsztajn P, Matysek J, Piwowarska W, Golay A. Relationship between hyperinsulinemia and angiographically defined coronary atherosclerosis in non-diabetic men. Diabetes Metab 2002; 28 (4 Part 1): 305-309.
20. Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M, Geshi E, Katagiri T. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. Am Heart J 2002; 144 (6): 1026-1035.
21. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels-a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165 (2): 285-292.
22. Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 1998; 44 (8 Part 1): 1641-1649.